BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10699729)

  • 1. Nuclear gene targeting using negatively charged liposomes.
    Welz C; Neuhuber W; Schreier H; Repp R; Rascher W; Fahr A
    Int J Pharm; 2000 Mar; 196(2):251-2. PubMed ID: 10699729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear transport of oligonucleotides in HepG2-cells mediated by protamine sulfate and negatively charged liposomes.
    Welz C; Neuhuber W; Schreier H; Metzler M; Repp R; Rascher W; Fahr A
    Pharm Res; 2000 Oct; 17(10):1206-11. PubMed ID: 11145225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted nucleotide exchange in the alkaline phosphatase gene of HuH-7 cells mediated by a chimeric RNA/DNA oligonucleotide.
    Kren BT; Cole-Strauss A; Kmiec EB; Steer CJ
    Hepatology; 1997 Jun; 25(6):1462-8. PubMed ID: 9185769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor.
    Bandyopadhyay P; Ma X; Linehan-Stieers C; Kren BT; Steer CJ
    J Biol Chem; 1999 Apr; 274(15):10163-72. PubMed ID: 10187800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutral liposome-mediated delivery process of fluorescein-modified oligonucleotides in cultured human keratinocytes.
    Sasaki M; Hayashi J; Fujii M; Koizumi K; Fujita H; Kobayashi M; Kawakubo Y; Ito A
    J Photochem Photobiol B; 2001 Jul; 60(2-3):120-8. PubMed ID: 11470568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional correction of episomal mutations with short DNA fragments and RNA-DNA oligonucleotides.
    Thorpe PH; Stevenson BJ; Porteous DJ
    J Gene Med; 2002; 4(2):195-204. PubMed ID: 11933220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene repair using chimeric RNA/DNA oligonucleotides.
    Kren BT; Metz R; Kumar R; Steer CJ
    Semin Liver Dis; 1999; 19(1):93-104. PubMed ID: 10349687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear extracts promote gene correction and strand pairing of oligonucleotides to the homologous plasmid.
    Igoucheva O; Alexeev V; Yoon K
    Antisense Nucleic Acid Drug Dev; 2002 Aug; 12(4):235-46. PubMed ID: 12238812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of a biosurfactant and protamine on gene transfection efficiency.
    Inoh Y; Furuno T; Hirashima N; Kitamoto D; Nakanishi M
    Eur J Pharm Sci; 2013 Apr; 49(1):1-9. PubMed ID: 23422688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted gene repair in mammalian cells using chimeric RNA/DNA oligonucleotides and modified single-stranded vectors.
    Parekh-Olmedo H; Czymmek K; Kmiec EB
    Sci STKE; 2001 Mar; 2001(73):pl1. PubMed ID: 11752645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes).
    Akhtar S; Basu S; Wickstrom E; Juliano RL
    Nucleic Acids Res; 1991 Oct; 19(20):5551-9. PubMed ID: 1945832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligonucleotide-cationic liposome interactions. A physicochemical study.
    Jääskeläinen I; Mönkkönen J; Urtti A
    Biochim Biophys Acta; 1994 Oct; 1195(1):115-23. PubMed ID: 7918553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.
    Hu Q; Bally MB; Madden TD
    Nucleic Acids Res; 2002 Aug; 30(16):3632-41. PubMed ID: 12177306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1.
    Stuart DD; Kao GY; Allen TM
    Cancer Gene Ther; 2000 Mar; 7(3):466-75. PubMed ID: 10766353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted gene correction by small single-stranded oligonucleotides in mammalian cells.
    Igoucheva O; Alexeev V; Yoon K
    Gene Ther; 2001 Mar; 8(5):391-9. PubMed ID: 11313816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo gene repair of point and frameshift mutations directed by chimeric RNA/DNA oligonucleotides and modified single-stranded oligonucleotides.
    Liu L; Rice MC; Kmiec EB
    Nucleic Acids Res; 2001 Oct; 29(20):4238-50. PubMed ID: 11600713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A plausible mechanism for gene correction by chimeric oligonucleotides.
    Gamper HB; Cole-Strauss A; Metz R; Parekh H; Kumar R; Kmiec EB
    Biochemistry; 2000 May; 39(19):5808-16. PubMed ID: 10801331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cationic cholesterol promotes gene transfection using the nuclear localization signal in protamine.
    Noguchi A; Hirashima N; Nakanishi M
    Pharm Res; 2002 Jul; 19(7):933-8. PubMed ID: 12180544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene repair and mutagenesis mediated by chimeric RNA-DNA oligonucleotides: chimeraplasty for gene therapy and conversion of single nucleotide polymorphisms (SNPs).
    Graham IR; Dickson G
    Biochim Biophys Acta; 2002 May; 1587(1):1-6. PubMed ID: 12009417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protamine-oligonucleotide-nanoparticles: Recent advances in drug delivery and drug targeting.
    Scheicher B; Schachner-Nedherer AL; Zimmer A
    Eur J Pharm Sci; 2015 Jul; 75():54-9. PubMed ID: 25896372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.